Kojima, M., Sone, K., Oda, K., Hamamoto, R., Kaneko, S., Oki, S., . . . Fujii, T. (2020). The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells. Oncol Lett.
Citação norma ChicagoKojima, Machiko, et al. "The Histone Methyltransferase SMYD2 Is a Novel Therapeutic Target for the Induction of Apoptosis in Ovarian Clear Cell Carcinoma Cells." Oncol Lett 2020.
Citação norma MLAKojima, Machiko, et al. "The Histone Methyltransferase SMYD2 Is a Novel Therapeutic Target for the Induction of Apoptosis in Ovarian Clear Cell Carcinoma Cells." Oncol Lett 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.